Proprietary AI analyst is now available

Fukuoka Financial Group Valuation Multiples

Discover Fukuoka Financial Group's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Huishang Bank Corp, Halyk Bank, VPBank, Bank Muscat and more.

Fukuoka Financial Group Overview

About Fukuoka Financial Group

Fukuoka Financial Group Inc is a Japan-based financial holding company that is principally engaged in the banking business through its subsidiaries, including the Bank of Fukuoka, the Kumamoto Bank, and the Shinwa Bank. The company conducts its core business (banking) through a branch network in Japan and overseas markets, including China, Thailand, Singapore, and the United States. The company also conducts other businesses, such as a securities business, an office work agent business, a loan guarantee business, a credit card business, a collateral valuation business, a consulting business, investments and loans, and others. The company generates the majority of its operating income from Japan.


Founded

2007

HQ

Japan

Employees

10.6K

Financials (LTM)

Revenue: $2B
Net Income: $560M

EV

$54B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Fukuoka Financial Group Financials

Fukuoka Financial Group reported last 12-month revenue of $2B.

In the same LTM period, Fukuoka Financial Group generated $560M in net income.

Revenue (LTM)


Fukuoka Financial Group P&L

In the most recent fiscal year, Fukuoka Financial Group reported revenue of $3B and net income of $540M.

Fukuoka Financial Group is profitable as of last fiscal year, with net margin of 21%.

See analyst estimates for Fukuoka Financial Group
LTMLast FY202320242025202620272028
Revenue$2B$3B$2B$2B$2B
EBIT Margin58%38%--41%
Net Profit$560M$540M$332M$429M$508M
Net Margin35%21%20%24%22%
Net Debt-$2B---

Financial data powered by Morningstar, Inc.

Fukuoka Financial Group Stock Performance

Fukuoka Financial Group has current market cap of $8B, and enterprise value of $54B.

Market Cap Evolution


Fukuoka Financial Group's stock price is $42.42.

Fukuoka Financial Group share price increased by 3.1% in the last 30 days, and by 74.7% in the last year.

Fukuoka Financial Group has an EPS (earnings per share) of $2.86.

See more trading valuation data for Fukuoka Financial Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$54B$8B-0.0%3.1%14.3%74.7%$2.86

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Fukuoka Financial Group Valuation Multiples

Fukuoka Financial Group trades at 33.4x EV/Revenue multiple.

See NTM and 2027E valuation multiples for Fukuoka Financial Group

EV / Revenue (LTM)


Fukuoka Financial Group Financial Valuation Multiples

As of June 29, 2026, Fukuoka Financial Group has market cap of $8B and EV of $54B.

Fukuoka Financial Group has a P/E ratio of 14.3x.

LTMLast FY202320242025202620272028
EV/Revenue33.4x21.2x32.4x30.0x22.8x
EV/EBIT57.1x56.0x--56.0x
P/E14.3x14.8x24.2x18.7x15.8x
EV/FCF-(33.2x)8.2xn/m(26.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Fukuoka Financial Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Fukuoka Financial Group Margins & Growth Rates

Fukuoka Financial Group decreased revenue by 20% but net profit grew by 15% in the last fiscal year.

In the most recent fiscal year, Fukuoka Financial Group reported net margin of 21%.

See estimated margins and future growth rates for Fukuoka Financial Group

Fukuoka Financial Group Margins

Last FY202420252026202720282029
EBIT Margin38%-41%42%
Net Margin21%24%22%28%
FCF Margin(64%)(10%)(86%)(75%)

Fukuoka Financial Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(20%)8%31%(9%)
EBIT Growth(8%)--(6%)
Net Profit Growth15%29%18%18%
FCF Growth-(103%)1066%(20%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Fukuoka Financial Group Operational KPIs

Fukuoka Financial Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Fukuoka Financial Group
Last FY202320242025202620272028
Revenue per Employee$0.2M---
Opex per Employee$0.2M---
G&A Expenses to Revenue42%55%54%45%
Opex to Revenue66%73%65%66%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Fukuoka Financial Group Competitors

Fukuoka Financial Group competitors include Huishang Bank Corp, Halyk Bank, VPBank, Bank Muscat, Jyske Bank, İşbank, Freedom Holding, Valley National Bank, Mebuki Financial Group and AU Small Finance Bank.

Most Fukuoka Financial Group public comparables operate across Commercial Banking.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Huishang Bank Corp10.8x11.0x--
Halyk Bank3.3x3.3x--
VPBank6.9x6.2x--
Bank Muscat6.8x6.6x--
Jyske Bank33.5x35.6x--
İşbank2.8x3.8x--
Freedom Holding3.0x-8.6x-
Valley National Bank5.7x5.4x--

This data is available for Pro users. Sign up to see all Fukuoka Financial Group competitors and their valuation data.

Start Free Trial

Investments by Fukuoka Financial Group

Fukuoka Financial Group has invested in 21 companies to date.

Latest investment by Fukuoka Financial Group was on June 11th 2021. Fukuoka Financial Group invested in Sonire Therapeutics in their $5M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Fukuoka Financial Group

Sonire Therapeutics
CellAxia
SQUEEZE
ATOMica
Description
Sonire Therapeutics is a developer of high-intensity focused ultrasound systems for cancer treatment leveraging advanced acoustic engineering. The Tokyo-based firm advances non-invasive HIFU platforms derived from academic research to target tumors in oncology applications.
CellAxia is a Tokyo-based biotechnology firm specializing in cell therapy drug discovery. The company advances regenerative medicines using induced pluripotent stem cells for cardiac and neural repair. Its pipeline includes candidates for heart failure and Parkinson's disease. CellAxia collaborates with Japanese pharmaceutical companies and research institutes on preclinical development. Established in 2017, it leverages proprietary differentiation protocols to produce clinical-grade cells.
SQUEEZE is a Tokyo-based hospitality technology provider that develops reservation management systems, table optimization software, and customer analytics tools for restaurants and hotels across Japan. Established in 2017, the company powers operations for over 5,000 venues, including chains like Torikizoku and Hotel Gracery, with its cloud platform handling 1 million reservations monthly. SQUEEZE focuses on real-time seating algorithms and CRM integrations to boost occupancy rates by 20 percent.
ATOMica is a Tokyo-based co-working space operator that manages conference rooms, event venues, and community hubs for businesses, schools, and individuals. It offers flexible booking for shared offices, meetings, seminars, and one-time events, while fostering local communities connecting students, workers, universities, and governments.
HQ CountryJapanJapanJapanJapan
HQ City
Tokyo
Tokyo
Tokyo
Miyazaki
Deal Date11 Jun 202111 Sep 20201 Apr 202026 Mar 2020
RoundSeries ASeries BSeries BSeed
Raised$5M$7M$8M$2M
InvestorsMAKOTO Capital; Fast Track Initiative; SBI Investment; EpiST Ventures; Mitsubishi UFJ Capital; Japan Science and Technology Agency; Fukuoka Financial Group; Higin CapitalM3 Inc.; Miyako Capital; Okasan Capital Partners; Mizuho Capital; Mitsubishi UFJ Capital; Fukuoka Financial GroupES-CON JAPAN; Fukuoka Financial Group; Canal VenturesIPPO; Miyazaki Taiyo Capital; Okamura; Fukuoka Financial Group; NOW Japan
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Fukuoka Financial Group investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Fukuoka Financial Group

When was Fukuoka Financial Group founded?Fukuoka Financial Group was founded in 2007.
Where is Fukuoka Financial Group headquartered?Fukuoka Financial Group is headquartered in Japan.
How many employees does Fukuoka Financial Group have?As of today, Fukuoka Financial Group has over 10K employees.
Is Fukuoka Financial Group publicly listed?Yes, Fukuoka Financial Group is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Fukuoka Financial Group?Fukuoka Financial Group trades under 8354 ticker.
When did Fukuoka Financial Group go public?Fukuoka Financial Group went public in 2007.
Who are competitors of Fukuoka Financial Group?Fukuoka Financial Group main competitors include Huishang Bank Corp, Halyk Bank, VPBank, Bank Muscat, Jyske Bank, İşbank, Freedom Holding, Valley National Bank, Mebuki Financial Group, AU Small Finance Bank.
What is the current market cap of Fukuoka Financial Group?Fukuoka Financial Group's current market cap is $8B.
What is the current revenue of Fukuoka Financial Group?Fukuoka Financial Group's last 12 months revenue is $2B.
What is the current revenue growth of Fukuoka Financial Group?Fukuoka Financial Group revenue growth (NTM/LTM) is 29%.
What is the current EV/Revenue multiple of Fukuoka Financial Group?Current revenue multiple of Fukuoka Financial Group is 33.4x.
What is the current net income of Fukuoka Financial Group?Fukuoka Financial Group's last 12 months net income is $560M.
How many companies Fukuoka Financial Group has acquired to date?Fukuoka Financial Group hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Fukuoka Financial Group has invested to date?As of June 2026, Fukuoka Financial Group has invested in 21 companies.
What was the last Fukuoka Financial Group investment?On 11th June 2021 Fukuoka Financial Group invested in Sonire Therapeutics, participating in a $5M Series A round, alongside MAKOTO Capital, Fast Track Initiative, SBI Investment, EpiST Ventures, Mitsubishi UFJ Capital, Japan Science and Technology Agency, and Higin Capital.
In what companies Fukuoka Financial Group invested in?Fukuoka Financial Group invested in ALI Technologies, QPS Holdings, iYell, SQUEEZE, Akippa, CellAxia, MONEY DESIGN, Sonire Therapeutics, Kipp Financial Technologies, VISITS Technologies, Linough, Audiostock, Richka, ATOMica, Oita University Institute of Advanced Medicine, Liberaware, Play Life, Petokoto, SYRUP Japan, FARMFES, and 1 other company.

See public comps similar to Fukuoka Financial Group

Lists including Fukuoka Financial Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial